Introgen Therapeutics, Inc. (INGNQ)
OTOTC · Common · CUSIP 46119F107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for INGNQ and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
46119F107
Market Cap
Small Cap · $103 Million
IPO
10/12/2000 · $8.00/share
Previous Symbol
INGN (changed 12/8/2008)
Business: Introgen Therapeutics, Inc. is a leading developer of gene therapy products for the treatment of cancer by capitalizing on the advances in the understanding of the human genome and the role that genetic function plays in the development of cancer.

Company Contact

Headquarters
301 Congress Avenue, Suite 1850, Austin, TX 78701
Phone
512-708-9310 · Toll-Free 877-776-4363
Fax
512-708-9311
Investor Relations
C. Channing Burke · 512-708-9310
Email Form
Request Form »
SEC EDGAR Filings
View filings »